Harbour BioMed Names Yajie Li as Chief Medical Officer
As Chief Medical Officer (CMO), Yajie Li will be based in Shanghai and report directly to Dr. Jingsong Wang, Founder, Chairman and CEO of Harbour BioMed.
Harbour BioMed | 25/08/2025 | By Dineshwori
WuXi Vaccines, Harbour BioMed in partnership for manufacturing facility
The 8,500-square-metre facility includes multiple 250L, 500L and 1000L single-use bioreactors as well as sterile drug-product manufacturing lines
<br />
Harbour BioMed | 21/11/2022 | By Sudeep Soparkar | 676
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy